Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs-Reference-Cited by-同舟云学术

Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs

Published:2020-01-01 Issue:1 Volume:5 Page:57
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Ornelas-Loredo Aylin¹,Kany Shinwan¹,Abraham Vihas¹,Alzahrani Zain¹,Darbar Faisal A.¹,Sridhar Arvind¹,Ahmed Maha¹,Alamar Ihab¹,Menon Ambili¹,Zhang Meihang¹,Chen Yining¹,Hong Liang¹,Konda Sreenivas²,Darbar Dawood¹³

Affiliation:

1. Division of Cardiology, Department of Medicine, University of Illinois at Chicago

2. Division of Epidemiology and Biostatistics, University of Illinois at Chicago

3. Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2756247/jamacardiology_ornelasloredo_2019_oi_190078.pdf

Reference35 articles.

1. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.;Benjamin;Circulation,1998

2. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.;Flegal;JAMA,2012

3. Genetic obesity and the risk of atrial fibrillation: causal estimates from mendelian randomization.;Chatterjee;Circulation,2017

4. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.;January;J Am Coll Cardiol,2014

5. Pulmonary vein isolation with vs without continued antiarrhythmic drug treatment in subjects with recurrent atrial fibrillation (POWDER AF): results from a multicentre randomized trial.;Duytschaever;Eur Heart J,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Obesity on the Use of Antiarrhythmics in Adults With Atrial Fibrillation: A Narrative Review;Clinical Cardiology;2024-08

2. Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications;Nature Reviews Cardiology;2024-05-30

3. Impact of Body Mass Index in the Cardioverter Efficacy of Amiodarone in Persistent Atrial Fibrillation;Pharmaceuticals;2024-05-28

4. Classification, Diagnosis, and Treatment of Obesity-Related Heart Diseases;Metabolic Syndrome and Related Disorders;2024-04-01

5. Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options;Journal of the American Heart Association;2024-01-02